Minoya Co., Ltd. (TYO:386A)

Theseus Pharmaceuticals Cash Flow Statement

Financials in millions JPY. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Net Income	714.24	391.35	-	-	-
Depreciation & Amortization	231.61	278.23	-	-	-
Loss (Gain) From Sale of Assets	71.86	-	-	-	-
Asset Writedown & Restructuring Costs	74.9	61.47	-	-	-
Other Operating Activities	-259.05	20.69	-	-	-
Change in Accounts Receivable	-324.74	-160.46	-	-	-
Change in Inventory	12.92	-119.08	-	-	-
Change in Accounts Payable	43.48	93.35	-	-	-
Change in Other Net Operating Assets	192.54	93.45	-	-	-
Operating Cash Flow	757.75	658.99	-	-	-
Operating Cash Flow Growth	14.99%	-	-	-	-
Capital Expenditures	-327.02	-	-	-	-
Sale of Property, Plant & Equipment	-	-327.75	-	-	-
Sale (Purchase) of Intangibles	-9.83	-0.32	-	-	-
Sale (Purchase) of Real Estate	-4.73	-1.88	-	-	-
Investment in Securities	-5.07	-4.71	-	-	-
Other Investing Activities	-61.36	-75.9	-	-	-
Investing Cash Flow	-408.01	-410.55	-	-	-
Long-Term Debt Issued	550	400	-	-	-
Short-Term Debt Repaid	-163.34	-50	-	-	-
Long-Term Debt Repaid	-535.05	-522.7	-	-	-
Total Debt Repaid	-698.39	-572.7	-	-	-
Net Debt Issued (Repaid)	-148.39	-172.7	-	-	-
Common Dividends Paid	-10.5	-9	-	-	-
Financing Cash Flow	-158.89	-181.7	-	-	-
Net Cash Flow	190.85	66.74	-	-	-
Free Cash Flow	430.73	658.99	-	-	-
Free Cash Flow Growth	-34.64%	-	-	-	-
Free Cash Flow Margin	1.91%	3.27%	-	-	-
Free Cash Flow Per Share	143.58	219.66	-	-	-
Cash Interest Paid	9.76	11.13	-	-	-
Cash Income Tax Paid	386.81	191.61	-	-	-
Levered Free Cash Flow	334.64	-	-	-	-
Unlevered Free Cash Flow	340.72	-	-	-	-
Change in Net Working Capital	140.47	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.